TriStar
Clinical Research Consulting, LLC

Learn what randomization means in clinical trials, why it matters, and how CRCs execute it at the site level using IRT systems.

Learn what maximum tolerated dose (MTD) means in clinical trials, how it's determined, and how it differs from RP2D and MFD.

Learn what HEOR means for your clinical trial site and how it shapes sponsor decisions, site selection, and the data you collect every visit.

How inclusion and exclusion criteria work in clinical trials and how research sites apply them accurately, from screening to sign-off.

How double-blind clinical trials work, why blinding matters, and what it means for research sites

Learn what Phase 4 clinical trials involve, why real-world evidence matters, and how TX/NM practices can start participating with support from TriStar CRC

Discover how Phase 2 clinical trials evaluate efficacy and optimize treatment. Learn what healthcare providers need to know about randomization, blinding, and site participation.

Discover how preclinical research tests safety and efficacy before human trials begin and what it means for the clinical trial pipeline.

Learn what Phase 1 clinical trials are, how maximum tolerated dose is determined, and why first-in-human studies are the foundation of drug development.

Discover how Site Management Organizations (SMOs) like TriStar CRC help private practices and clinics launch clinical trials—without building research infrastructure from scratch

Learn who does what in a clinical trial — PI, CRC, and CRA roles explained. Discover how private practices and specialty clinics can participate in clinical research with the right support.

Learn how clinical trial phases work. From preclinical to Phase 4 and how TriStar CRC helps providers and clinics become research sites with full support.

Learn how clinical research works with this guide, who the key players are, and how your practice can participate in clinical trials. TriStar helps sites get started with expert setup and full operational support.